ATE355069T1 - Verfahren zur herstellung polyvalenter bakteriophagenpräparationen zur behandlung bakterieller infektionen - Google Patents

Verfahren zur herstellung polyvalenter bakteriophagenpräparationen zur behandlung bakterieller infektionen

Info

Publication number
ATE355069T1
ATE355069T1 AT02751919T AT02751919T ATE355069T1 AT E355069 T1 ATE355069 T1 AT E355069T1 AT 02751919 T AT02751919 T AT 02751919T AT 02751919 T AT02751919 T AT 02751919T AT E355069 T1 ATE355069 T1 AT E355069T1
Authority
AT
Austria
Prior art keywords
treatment
bacterial infections
bacteriophage preparations
polyvalent bacteriophage
producing polyvalent
Prior art date
Application number
AT02751919T
Other languages
English (en)
Inventor
Beata Weber-Dabrowska
Marian Mulczyk
Andrzej Gorski
Janusz Boratynski
Marzanna Lusiak-Szelachowska
Danuta Syper
Original Assignee
Inst Immunologii I Terapii Dos
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PL348740A external-priority patent/PL195437B1/pl
Priority claimed from PL02354822A external-priority patent/PL354822A1/xx
Application filed by Inst Immunologii I Terapii Dos filed Critical Inst Immunologii I Terapii Dos
Application granted granted Critical
Publication of ATE355069T1 publication Critical patent/ATE355069T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02—Recovery or purification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/00032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT02751919T 2001-07-18 2002-07-18 Verfahren zur herstellung polyvalenter bakteriophagenpräparationen zur behandlung bakterieller infektionen ATE355069T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL348740A PL195437B1 (pl) 2001-07-18 2001-07-18 Sposób przygotowania poliwalentnych preparatów fagowych do leczenia zakażeń bakteryjnych
PL02354822A PL354822A1 (en) 2002-06-30 2002-06-30 Method of receiving purified bacteriophage preparations and new applications of polysaccharide or its esterificated derivative

Publications (1)

Publication Number Publication Date
ATE355069T1 true ATE355069T1 (de) 2006-03-15

Family

ID=26653403

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02751919T ATE355069T1 (de) 2001-07-18 2002-07-18 Verfahren zur herstellung polyvalenter bakteriophagenpräparationen zur behandlung bakterieller infektionen

Country Status (12)

Country Link
US (1) US7232564B2 (de)
EP (1) EP1406642B1 (de)
JP (1) JP4723807B2 (de)
KR (1) KR100874888B1 (de)
CN (1) CN1260353C (de)
AT (1) ATE355069T1 (de)
AU (1) AU2002354900A1 (de)
DE (1) DE60218473T2 (de)
DK (1) DK1406642T3 (de)
EA (1) EA007472B1 (de)
ES (1) ES2283581T3 (de)
WO (1) WO2003008564A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL354822A1 (en) * 2002-06-30 2004-01-12 Instytut Immunologii i Terapii Doświadczalnej PANwe Wrocławiu Method of receiving purified bacteriophage preparations and new applications of polysaccharide or its esterificated derivative
EP1663265B1 (de) 2003-07-23 2015-09-23 Biocontrol Limited Bakteriophagen-enthaltende medikamente
EP1853918A1 (de) * 2005-03-04 2007-11-14 Blaze Venture Technologies Limited Verfahren und vorrichtung zur entnahme von bakterienproben
CN100413962C (zh) * 2005-06-16 2008-08-27 华中科技大学同济医学院附属同济医院 一种作用于产超广谱β-内酰胺酶大肠杆菌噬菌体
AU2006268420B2 (en) * 2005-07-12 2012-06-28 Micreos B.V. Bacteriophage and their uses
US20070292397A1 (en) * 2006-06-19 2007-12-20 Mcnulty Amy K Method for the detection and neutralization of bacteria
GB0704553D0 (en) 2007-03-09 2007-04-18 Harper David R Beneficial effects of bacteriophage treatments
JP5720045B2 (ja) * 2008-12-26 2015-05-20 国立大学法人東京工業大学 スタフィロコッカス・アウレウス溶菌性バクテリオファージ
KR100952201B1 (ko) 2009-07-10 2010-04-09 주식회사 엘에스텍 레이저를 이용한 패턴형성장치
KR100935387B1 (ko) 2009-07-10 2010-01-06 주식회사 엘에스텍 레이저를 이용한 패턴형성장치
KR100952202B1 (ko) 2009-09-11 2010-04-09 주식회사 엘에스텍 도광판용 패턴형성장치
RU2474431C1 (ru) * 2011-08-09 2013-02-10 Татьяна Николаевна Зарипова Способ лечения острых и обострений хронического ларингита
CN103555673B (zh) * 2013-10-23 2016-01-20 靳静 体外筛选体内抗菌活性噬菌体的方法
RU2664681C1 (ru) * 2017-09-06 2018-08-21 Андрей Владимирович Алешкин Способ лечения инфекции, связанной с оказанием медицинской помощи, вызванной возбудителем или возбудителями с множественной лекарственной устойчивостью
KR102774411B1 (ko) * 2021-10-27 2025-02-27 전북대학교산학협력단 재증식 풀 컬쳐 기반 박테리오파지 스크리닝 방법

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB829266A (en) * 1957-03-20 1960-03-02 Biogena A method of manufacturing bacteriophages in solid dry form
SU543260A1 (ru) 1975-07-25 1984-04-15 Всесоюзный Ордена Трудового Красного Знамени Научно-Исследовательский Противочумный Институт "Микроб" Способ получени холерных бактериофагов дл дифференциации вибрионов Эль-Тор на вирулентные и авирулентные
CS192212B1 (en) 1977-04-22 1979-08-31 Miloslav Mazacek Method of producing dry form bacteriophages
US4118315A (en) * 1977-04-28 1978-10-03 Nasa Water system virus detection
US4797363A (en) * 1984-03-19 1989-01-10 Board Of Trustees, University Of Illinois Bacteriophages as recognition and identification agents
US4828999A (en) * 1986-07-21 1989-05-09 Jackson Le Roy E Bacteriophage prevention and control of harmful plant bacteria
EP0290295B1 (de) 1987-05-07 1992-08-05 Microbial Developments Limited Antimikrobische Zubereitungen
WO1990003122A1 (en) 1988-09-26 1990-04-05 Microbial Developments Limited Antimicrobial preparations
US5846604A (en) * 1988-03-14 1998-12-08 Nextec Applications, Inc. Controlling the porosity and permeation of a web
GB8918983D0 (en) 1989-08-21 1989-10-04 Unilever Plc Composition for hygiene purposes
DE4005874A1 (de) 1990-02-24 1991-11-07 Boehringer Mannheim Gmbh Traegergebundene rekombinante proteine, verfahren zur herstellung und verwendung als immunogene und vakzine
GB2253859A (en) 1991-02-28 1992-09-23 Microbial Dev Ltd Use of bacteriophages to prevent microbial infestation
GB2255561B (en) 1991-04-20 1995-06-21 Agricultural & Food Res Lysins from bacteriophages
WO1995005454A1 (en) 1992-02-22 1995-02-23 Cambridge Bacteriophage Technologies Ltd. Engineered bacteriophages and vaccines containing them
GB9220027D0 (en) 1992-09-22 1992-11-04 Mini Agriculture & Fisheries Method and kits for detection of bacteria
WO1996007329A1 (en) 1994-09-09 1996-03-14 University Of Maryland Bacteriophage-encoded enzymes for the treatment and prevention of dental caries and periodontal diseases
GB9500851D0 (en) 1995-01-17 1995-03-08 Bionvent International Ab Method of selecting specific bacteriophages
DE19517940A1 (de) 1995-05-18 1996-11-21 Merck Patent Gmbh Nachweis von Listerien mittels rekombinanter Bakteriophagen
JP2000508322A (ja) * 1996-04-15 2000-07-04 エヌワイエムオーエックス コーポレーション バクテリオファージを含有する組成物および感染症を治療するためのバクテリオファージの使用方法
US6322783B1 (en) 1996-08-26 2001-11-27 Seishi Takahashi Bacteriophages, method for screening same and bactericidal compositions using same, and detection kits using same
WO1998008944A1 (fr) 1996-08-26 1998-03-05 Bio Venture Bank Co., Ltd. Nouveau bacteriophage et procede de criblage associe, nouvelles matieres biobactericides preparees avec ledit bacteriophage et reactif utilise pour detecter celui-ci
RU2109055C1 (ru) * 1996-11-27 1998-04-20 Дочернее предприятие "Биофаг" Научно-производственного объединения "Иммунопрепарат" Способ выделения бактериофагов
DE19828596A1 (de) * 1997-06-26 1999-02-11 A Daniela Dr Nodar Wirksames Arzneimittel gegen bakterielle Erkrankungen und Herstellung desselben
US6982153B1 (en) * 1998-12-03 2006-01-03 Targanta Therapeutics, Inc. DNA sequences from staphylococcus aureus bacteriophage 77 that encode anti-microbial polypeptides
US6245504B1 (en) * 1999-03-26 2001-06-12 The University Of Georgia Research Foundation, Inc. Transducing phages of Actinomycetales
US6482632B1 (en) * 1999-03-29 2002-11-19 Council Of Scientic And Industrial Research Bacteriophage, a process for the isolation thereof, and a universal growth medium useful in the process thereof
JP2002541822A (ja) * 1999-04-14 2002-12-10 エム ユー エス シー ファンデーション フォー リサーチ ディベロップメント 組織特異的および病原体特異的毒性物質ならびにリボザイム
AU5423400A (en) 1999-06-25 2001-01-31 Spring Diagnostics Ltd. Bacteriophage library useful for typing bacteria and system and method utilizingsame
ES2256028T3 (es) 1999-07-30 2006-07-16 Profos Ag Deteccion e identificacion de cepas bacterianas.
CN1230206C (zh) * 2000-01-11 2005-12-07 内立蒂克斯股份有限公司 作为生产生物复合材料的生物可降解基质的聚合物混合物
ATE305793T1 (de) * 2000-07-25 2005-10-15 Us Gov Health & Human Serv Bakteriophage mit breitem wirtspektrum
US6461608B1 (en) * 2000-11-22 2002-10-08 Nymox Pharmaceutical Corporation Bacteriophage composition useful in treating food products to prevent bacterial contamination

Also Published As

Publication number Publication date
JP4723807B2 (ja) 2011-07-13
EA007472B1 (ru) 2006-10-27
WO2003008564A3 (en) 2003-11-06
AU2002354900A1 (en) 2003-03-03
EP1406642A2 (de) 2004-04-14
EP1406642B1 (de) 2007-02-28
US20050032036A1 (en) 2005-02-10
CN1541101A (zh) 2004-10-27
EA200400197A1 (ru) 2004-06-24
KR100874888B1 (ko) 2008-12-19
WO2003008564A2 (en) 2003-01-30
DE60218473T2 (de) 2007-11-08
CN1260353C (zh) 2006-06-21
DE60218473D1 (de) 2007-04-12
JP2004535812A (ja) 2004-12-02
DK1406642T3 (da) 2007-07-02
US7232564B2 (en) 2007-06-19
KR20040029372A (ko) 2004-04-06
ES2283581T3 (es) 2007-11-01

Similar Documents

Publication Publication Date Title
ATE355069T1 (de) Verfahren zur herstellung polyvalenter bakteriophagenpräparationen zur behandlung bakterieller infektionen
DE60123276D1 (de) Piperazinderivate zur behandlung bakterieller infektionen
EP1385476A4 (de) Verfahren zur diagnostizierung und behandlung von bakterienwucherung im dünndarum (sibo) und damit zusammenhängenden erkrankungen
CY1112560T1 (el) Πνευμονικη μεταφορα των αμινογλυκοσιδων
WO2003096989A3 (en) Anti tubercular drug: compositions and methods
DE602005019064D1 (de) Verfahren zur herstellung gefriergetrockneter blutplättchen, gefriergetrocknete blutplättchen enthaltende zusammensetzungen und verwendungsverfahren
AU2003220970A1 (en) Diamino-pyrimidines and their use as angiogenesis inhibitors
EA200300929A1 (ru) Новые лекарственные композиции на основе антихолинергических средств и ингибиторов pde-iv
ATE258057T1 (de) Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen
DE60222296D1 (de) Impfstoff von umhüllten viren und verfahren zu seiner herstellung
WO2005034857A3 (en) Methods and compositions comprising diamines as new anti-tubercular therapeutics
IL159479A (en) Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis
DE60142786D1 (de) Zusammensetzungen und methoden zur behandlung von candidosen
ATE433459T1 (de) Desoxo-nonadepsipeptide
NO20062469L (no) Streptococcus phocae vaksine
ATE460168T1 (de) Nicht-radioaktives strontiummittel zur behandlung von krebs
ATE455789T1 (de) Substituierte nonadepsipeptide
ATE545421T1 (de) Pharmazeutisches präparat zur behandlung von parasitären tropenkrankheiten enthaltend diminazen-di-aceturat
WO2003096987A9 (en) Methods of use and compositions for the diagnosis and treatment of infectious disease
DE60229624D1 (de) Peroxiredoxin-arzneistoffe zur behandlung einer hiv-1-infektion
DE60024977D1 (de) Klonierung und expression von haemophilus somnus transferrin-bindenden proteinen
NO20042711L (no) Fremgangsmate for a behandle bakterielle infeksjoner ved anvendelse av gemifloksasin eller et salt derav et betalaktamantibiotikum
AR027738A1 (es) Composicion coadyuvante, composiciones de vacunas que incluyen dicha composicion coadyuvante; procedimiento de induccion de inmunorespuestas antigenicas enmamiferos y procedimiento de tratamiento donde se aplican dichas vacunas
DE502006004735D1 (de) Mittel zur behandlung von infektionen
PL348740A1 (en) Method of preparing polyvalent phage-type preparations for use in treating bacterial infections

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1406642

Country of ref document: EP